Prospective open-label, multicenter phase IV study of liver-function-adjusted tacrolimus therapy after liver transplantation.
Phase of Trial: Phase IV
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Pharmacokinetics
- Acronyms GRAFTT
- 07 Jun 2014 Trial status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 03 Jul 2013 New source identified and integrated (German Clinical Trials Register record: DRKS00003551).
- 19 Mar 2012 New trial record